Grant: Discovery Grants Program - Individual
McGill University
$32,000.00
Function of the alternatively spliced p53 gene
FY 2009-10
Summary
The human p53 gene is among the most intensely studied because it is the prototype tumor suppressor gene. p53 is considered the prototype tumor suppressor because genetically engineered p53 null knockout mice acquire multiple tumors very early in life but are otherwise normal, human families with germline mutations in the p53 gene are highly cancer prone, and p53 is the most common mutated gene in human cancers. Interestingly, most tumors express mutant forms of p53 as opposed to loss of p53 expression and the reason for this remains poorly understood. The p53 protein is a DNA binding transcriptional transactivator that mediates the expression of cellular genes whose products impair the cell cycle and induce apoptosis. Loss of normal cellular p53 function favors tumorigenesis and also renders tumor cells resistant to chemo- and radiotherapy. With the support of NSERC during our last funding period, we discovered that alternative splicing of the human p53 gene results in the expression of a N-terminal truncated form of p53 termed deltaNp53(p47) which is capable of interacting with and inhibiting the full length p53. A major question to be addressed in this proposal is whether deltaNp53(p47) behaves similar to tumor derived mutant p53 and more generally what is the function of deltaNp53(p47). This research could provide a better understanding of why many tumors express a mutant p53.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
3475-2009
Name nom
Matlashewski, Gregory
Department département
Microbiology and Immunology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
32000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
5
Application title
Function of the alternatively spliced p53 gene
Keyword
NA
Application summary
The human p53 gene is among the most intensely studied because it is the prototype tumor suppressor gene. p53 is considered the prototype tumor suppressor because genetically engineered p53 null knockout mice acquire multiple tumors very early in life but are otherwise normal, human families with germline mutations in the p53 gene are highly cancer prone, and p53 is the most common mutated gene in human cancers. Interestingly, most tumors express mutant forms of p53 as opposed to loss of p53 expression and the reason for this remains poorly understood. The p53 protein is a DNA binding transcriptional transactivator that mediates the expression of cellular genes whose products impair the cell cycle and induce apoptosis. Loss of normal cellular p53 function favors tumorigenesis and also renders tumor cells resistant to chemo- and radiotherapy. With the support of NSERC during our last funding period, we discovered that alternative splicing of the human p53 gene results in the expression of a N-terminal truncated form of p53 termed deltaNp53(p47) which is capable of interacting with and inhibiting the full length p53. A major question to be addressed in this proposal is whether deltaNp53(p47) behaves similar to tumor derived mutant p53 and more generally what is the function of deltaNp53(p47). This research could provide a better understanding of why many tumors express a mutant p53.